Hot Picks: Biotech stocks to watch as Phase III data and FDA decisions near [BNN Bloomberg (Canada)]
United Therapeutics (NASDAQ:UTHR) had its "buy" rating reaffirmed by analysts at UBS Group AG.
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026 [Yahoo! Finance]
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026
United Therapeutics: In Progress -- New Organs For Old At Scale [Seeking Alpha]